nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—CYP3A4—type 2 diabetes mellitus	0.15	0.534	CbGaD
Alfentanil—ALB—type 2 diabetes mellitus	0.131	0.466	CbGaD
Alfentanil—ORM1—Nateglinide—type 2 diabetes mellitus	0.0589	0.111	CbGbCtD
Alfentanil—ALB—Gliclazide—type 2 diabetes mellitus	0.0385	0.0722	CbGbCtD
Alfentanil—ALB—Repaglinide—type 2 diabetes mellitus	0.0362	0.0679	CbGbCtD
Alfentanil—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0302	0.0567	CbGbCtD
Alfentanil—ALB—Valsartan—type 2 diabetes mellitus	0.0267	0.05	CbGbCtD
Alfentanil—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0266	0.0499	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0266	0.0499	CbGbCtD
Alfentanil—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0265	0.0498	CbGbCtD
Alfentanil—ALB—Nateglinide—type 2 diabetes mellitus	0.0248	0.0465	CbGbCtD
Alfentanil—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0237	0.0444	CbGbCtD
Alfentanil—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0199	0.0374	CbGbCtD
Alfentanil—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0171	0.0321	CbGbCtD
Alfentanil—ALB—Glyburide—type 2 diabetes mellitus	0.0167	0.0314	CbGbCtD
Alfentanil—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0159	0.0299	CbGbCtD
Alfentanil—ALB—Losartan—type 2 diabetes mellitus	0.0153	0.0287	CbGbCtD
Alfentanil—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0142	0.0266	CbGbCtD
Alfentanil—CYP3A4—Glipizide—type 2 diabetes mellitus	0.013	0.0243	CbGbCtD
Alfentanil—CYP3A5—Losartan—type 2 diabetes mellitus	0.0123	0.0231	CbGbCtD
Alfentanil—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0118	0.0221	CbGbCtD
Alfentanil—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0113	0.0213	CbGbCtD
Alfentanil—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0102	0.0192	CbGbCtD
Alfentanil—ABCB1—Glyburide—type 2 diabetes mellitus	0.00876	0.0164	CbGbCtD
Alfentanil—ABCB1—Losartan—type 2 diabetes mellitus	0.00801	0.015	CbGbCtD
Alfentanil—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00777	0.0146	CbGbCtD
Alfentanil—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00745	0.014	CbGbCtD
Alfentanil—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00745	0.014	CbGbCtD
Alfentanil—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00704	0.0132	CbGbCtD
Alfentanil—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00525	0.00985	CbGbCtD
Alfentanil—CYP3A4—Losartan—type 2 diabetes mellitus	0.0048	0.00901	CbGbCtD
Alfentanil—Sufentanil—CYP3A4—type 2 diabetes mellitus	0.000323	0.746	CrCbGaD
Alfentanil—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000232	0.0018	CcSEcCtD
Alfentanil—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000232	0.00179	CcSEcCtD
Alfentanil—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000232	0.00179	CcSEcCtD
Alfentanil—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000232	0.00179	CcSEcCtD
Alfentanil—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000231	0.00179	CcSEcCtD
Alfentanil—Chills—Metformin—type 2 diabetes mellitus	0.000231	0.00179	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00023	0.00178	CcSEcCtD
Alfentanil—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00023	0.00177	CcSEcCtD
Alfentanil—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000229	0.00177	CcSEcCtD
Alfentanil—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000228	0.00176	CcSEcCtD
Alfentanil—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000228	0.00176	CcSEcCtD
Alfentanil—Hypotension—Glyburide—type 2 diabetes mellitus	0.000227	0.00176	CcSEcCtD
Alfentanil—Nausea—Repaglinide—type 2 diabetes mellitus	0.000227	0.00176	CcSEcCtD
Alfentanil—Asthenia—Glipizide—type 2 diabetes mellitus	0.000227	0.00175	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000226	0.00175	CcSEcCtD
Alfentanil—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000226	0.00175	CcSEcCtD
Alfentanil—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000225	0.00174	CcSEcCtD
Alfentanil—Erythema—Metformin—type 2 diabetes mellitus	0.000224	0.00173	CcSEcCtD
Alfentanil—Pruritus—Glipizide—type 2 diabetes mellitus	0.000224	0.00173	CcSEcCtD
Alfentanil—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000223	0.00173	CcSEcCtD
Alfentanil—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00022	0.0017	CcSEcCtD
Alfentanil—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00022	0.0017	CcSEcCtD
Alfentanil—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000219	0.0017	CcSEcCtD
Alfentanil—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000219	0.0017	CcSEcCtD
Alfentanil—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000219	0.00169	CcSEcCtD
Alfentanil—Chills—Irbesartan—type 2 diabetes mellitus	0.000218	0.00169	CcSEcCtD
Alfentanil—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000217	0.00168	CcSEcCtD
Alfentanil—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000217	0.00168	CcSEcCtD
Alfentanil—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000217	0.00168	CcSEcCtD
Alfentanil—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000217	0.00168	CcSEcCtD
Alfentanil—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000216	0.00167	CcSEcCtD
Alfentanil—Cough—Valsartan—type 2 diabetes mellitus	0.000215	0.00166	CcSEcCtD
Alfentanil—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000215	0.00166	CcSEcCtD
Alfentanil—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000214	0.00166	CcSEcCtD
Alfentanil—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000213	0.00165	CcSEcCtD
Alfentanil—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000212	0.00164	CcSEcCtD
Alfentanil—Cough—Orlistat—type 2 diabetes mellitus	0.000212	0.00164	CcSEcCtD
Alfentanil—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000212	0.00164	CcSEcCtD
Alfentanil—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000211	0.00164	CcSEcCtD
Alfentanil—Erythema—Irbesartan—type 2 diabetes mellitus	0.000211	0.00163	CcSEcCtD
Alfentanil—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000211	0.00163	CcSEcCtD
Alfentanil—Vision blurred—Metformin—type 2 diabetes mellitus	0.000211	0.00163	CcSEcCtD
Alfentanil—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00163	CcSEcCtD
Alfentanil—Convulsion—Orlistat—type 2 diabetes mellitus	0.000211	0.00163	CcSEcCtD
Alfentanil—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00163	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00021	0.00162	CcSEcCtD
Alfentanil—Dizziness—Glipizide—type 2 diabetes mellitus	0.000209	0.00162	CcSEcCtD
Alfentanil—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000209	0.00161	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000208	0.00161	CcSEcCtD
Alfentanil—Angiopathy—Losartan—type 2 diabetes mellitus	0.000207	0.0016	CcSEcCtD
Alfentanil—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000206	0.00159	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000206	0.00159	CcSEcCtD
Alfentanil—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000204	0.00158	CcSEcCtD
Alfentanil—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000204	0.00158	CcSEcCtD
Alfentanil—Vomiting—Glipizide—type 2 diabetes mellitus	0.000201	0.00155	CcSEcCtD
Alfentanil—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000201	0.00155	CcSEcCtD
Alfentanil—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000201	0.00155	CcSEcCtD
Alfentanil—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.0002	0.00155	CcSEcCtD
Alfentanil—Rash—Glipizide—type 2 diabetes mellitus	0.000199	0.00154	CcSEcCtD
Alfentanil—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000199	0.00154	CcSEcCtD
Alfentanil—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000199	0.00154	CcSEcCtD
Alfentanil—Erythema—Losartan—type 2 diabetes mellitus	0.000199	0.00154	CcSEcCtD
Alfentanil—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000198	0.00153	CcSEcCtD
Alfentanil—Headache—Glipizide—type 2 diabetes mellitus	0.000198	0.00153	CcSEcCtD
Alfentanil—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000197	0.00152	CcSEcCtD
Alfentanil—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000197	0.00152	CcSEcCtD
Alfentanil—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000195	0.00151	CcSEcCtD
Alfentanil—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000195	0.00151	CcSEcCtD
Alfentanil—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000195	0.0015	CcSEcCtD
Alfentanil—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000195	0.0015	CcSEcCtD
Alfentanil—Agitation—Irbesartan—type 2 diabetes mellitus	0.000194	0.0015	CcSEcCtD
Alfentanil—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000194	0.0015	CcSEcCtD
Alfentanil—Hypertension—Metformin—type 2 diabetes mellitus	0.000193	0.0015	CcSEcCtD
Alfentanil—Urticaria—Glyburide—type 2 diabetes mellitus	0.000193	0.0015	CcSEcCtD
Alfentanil—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000193	0.00149	CcSEcCtD
Alfentanil—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000193	0.00149	CcSEcCtD
Alfentanil—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000192	0.00148	CcSEcCtD
Alfentanil—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00148	CcSEcCtD
Alfentanil—Headache—Pioglitazone—type 2 diabetes mellitus	0.00019	0.00147	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000189	0.00146	CcSEcCtD
Alfentanil—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000189	0.00146	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000189	0.00146	CcSEcCtD
Alfentanil—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000188	0.00146	CcSEcCtD
Alfentanil—Nausea—Glipizide—type 2 diabetes mellitus	0.000188	0.00145	CcSEcCtD
Alfentanil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000188	0.00145	CcSEcCtD
Alfentanil—Hypotension—Valsartan—type 2 diabetes mellitus	0.000188	0.00145	CcSEcCtD
Alfentanil—Vision blurred—Losartan—type 2 diabetes mellitus	0.000187	0.00145	CcSEcCtD
Alfentanil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000187	0.00145	CcSEcCtD
Alfentanil—Pain—Gliclazide—type 2 diabetes mellitus	0.000187	0.00145	CcSEcCtD
Alfentanil—Rash—Glimepiride—type 2 diabetes mellitus	0.000186	0.00144	CcSEcCtD
Alfentanil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000186	0.00144	CcSEcCtD
Alfentanil—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000186	0.00144	CcSEcCtD
Alfentanil—Rash—Sitagliptin—type 2 diabetes mellitus	0.000185	0.00143	CcSEcCtD
Alfentanil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000185	0.00143	CcSEcCtD
Alfentanil—Headache—Glimepiride—type 2 diabetes mellitus	0.000185	0.00143	CcSEcCtD
Alfentanil—Cough—Irbesartan—type 2 diabetes mellitus	0.000184	0.00143	CcSEcCtD
Alfentanil—Headache—Sitagliptin—type 2 diabetes mellitus	0.000184	0.00143	CcSEcCtD
Alfentanil—Agitation—Losartan—type 2 diabetes mellitus	0.000183	0.00141	CcSEcCtD
Alfentanil—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000183	0.00141	CcSEcCtD
Alfentanil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00018	0.00139	CcSEcCtD
Alfentanil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000179	0.00139	CcSEcCtD
Alfentanil—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000179	0.00139	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000179	0.00138	CcSEcCtD
Alfentanil—Somnolence—Valsartan—type 2 diabetes mellitus	0.000178	0.00138	CcSEcCtD
Alfentanil—Skin disorder—Metformin—type 2 diabetes mellitus	0.000178	0.00137	CcSEcCtD
Alfentanil—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000177	0.00137	CcSEcCtD
Alfentanil—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000177	0.00137	CcSEcCtD
Alfentanil—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000177	0.00137	CcSEcCtD
Alfentanil—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000176	0.00136	CcSEcCtD
Alfentanil—Nausea—Glimepiride—type 2 diabetes mellitus	0.000175	0.00136	CcSEcCtD
Alfentanil—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000175	0.00135	CcSEcCtD
Alfentanil—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000175	0.00135	CcSEcCtD
Alfentanil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00135	CcSEcCtD
Alfentanil—Asthenia—Glyburide—type 2 diabetes mellitus	0.000175	0.00135	CcSEcCtD
Alfentanil—Cough—Losartan—type 2 diabetes mellitus	0.000174	0.00134	CcSEcCtD
Alfentanil—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000174	0.00134	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000173	0.00134	CcSEcCtD
Alfentanil—Fatigue—Valsartan—type 2 diabetes mellitus	0.000173	0.00134	CcSEcCtD
Alfentanil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000173	0.00134	CcSEcCtD
Alfentanil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000173	0.00133	CcSEcCtD
Alfentanil—Pruritus—Glyburide—type 2 diabetes mellitus	0.000172	0.00133	CcSEcCtD
Alfentanil—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.00133	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000171	0.00132	CcSEcCtD
Alfentanil—Fatigue—Orlistat—type 2 diabetes mellitus	0.000171	0.00132	CcSEcCtD
Alfentanil—Hypotension—Metformin—type 2 diabetes mellitus	0.000171	0.00132	CcSEcCtD
Alfentanil—Erythema—Ramipril—type 2 diabetes mellitus	0.000171	0.00132	CcSEcCtD
Alfentanil—Pain—Orlistat—type 2 diabetes mellitus	0.00017	0.00131	CcSEcCtD
Alfentanil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000169	0.00131	CcSEcCtD
Alfentanil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000169	0.00131	CcSEcCtD
Alfentanil—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000168	0.0013	CcSEcCtD
Alfentanil—Rash—Bromocriptine—type 2 diabetes mellitus	0.000168	0.0013	CcSEcCtD
Alfentanil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000168	0.0013	CcSEcCtD
Alfentanil—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000168	0.0013	CcSEcCtD
Alfentanil—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000167	0.00129	CcSEcCtD
Alfentanil—Headache—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00129	CcSEcCtD
Alfentanil—Confusional state—Losartan—type 2 diabetes mellitus	0.000164	0.00127	CcSEcCtD
Alfentanil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000163	0.00126	CcSEcCtD
Alfentanil—Somnolence—Metformin—type 2 diabetes mellitus	0.000163	0.00126	CcSEcCtD
Alfentanil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000162	0.00126	CcSEcCtD
Alfentanil—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000161	0.00125	CcSEcCtD
Alfentanil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000161	0.00125	CcSEcCtD
Alfentanil—Urticaria—Valsartan—type 2 diabetes mellitus	0.000159	0.00123	CcSEcCtD
Alfentanil—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000159	0.00123	CcSEcCtD
Alfentanil—Tachycardia—Losartan—type 2 diabetes mellitus	0.000158	0.00123	CcSEcCtD
Alfentanil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00122	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000158	0.00122	CcSEcCtD
Alfentanil—Fatigue—Metformin—type 2 diabetes mellitus	0.000158	0.00122	CcSEcCtD
Alfentanil—Urticaria—Orlistat—type 2 diabetes mellitus	0.000158	0.00122	CcSEcCtD
Alfentanil—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000157	0.00121	CcSEcCtD
Alfentanil—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000157	0.00121	CcSEcCtD
Alfentanil—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000157	0.00121	CcSEcCtD
Alfentanil—Agitation—Ramipril—type 2 diabetes mellitus	0.000157	0.00121	CcSEcCtD
Alfentanil—Vomiting—Glyburide—type 2 diabetes mellitus	0.000155	0.0012	CcSEcCtD
Alfentanil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000155	0.0012	CcSEcCtD
Alfentanil—Rash—Glyburide—type 2 diabetes mellitus	0.000153	0.00119	CcSEcCtD
Alfentanil—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000153	0.00119	CcSEcCtD
Alfentanil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000153	0.00119	CcSEcCtD
Alfentanil—Headache—Glyburide—type 2 diabetes mellitus	0.000152	0.00118	CcSEcCtD
Alfentanil—Hypotension—Losartan—type 2 diabetes mellitus	0.000152	0.00117	CcSEcCtD
Alfentanil—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000151	0.00117	CcSEcCtD
Alfentanil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00015	0.00116	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000149	0.00115	CcSEcCtD
Alfentanil—Cough—Ramipril—type 2 diabetes mellitus	0.000149	0.00115	CcSEcCtD
Alfentanil—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000149	0.00115	CcSEcCtD
Alfentanil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000148	0.00114	CcSEcCtD
Alfentanil—Convulsion—Ramipril—type 2 diabetes mellitus	0.000148	0.00114	CcSEcCtD
Alfentanil—Pain—Irbesartan—type 2 diabetes mellitus	0.000148	0.00114	CcSEcCtD
Alfentanil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000146	0.00113	CcSEcCtD
Alfentanil—Urticaria—Metformin—type 2 diabetes mellitus	0.000145	0.00112	CcSEcCtD
Alfentanil—Nausea—Glyburide—type 2 diabetes mellitus	0.000145	0.00112	CcSEcCtD
Alfentanil—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000144	0.00112	CcSEcCtD
Alfentanil—Somnolence—Losartan—type 2 diabetes mellitus	0.000144	0.00112	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000144	0.00112	CcSEcCtD
Alfentanil—Asthenia—Valsartan—type 2 diabetes mellitus	0.000144	0.00111	CcSEcCtD
Alfentanil—Asthenia—Orlistat—type 2 diabetes mellitus	0.000142	0.0011	CcSEcCtD
Alfentanil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000142	0.0011	CcSEcCtD
Alfentanil—Pruritus—Valsartan—type 2 diabetes mellitus	0.000142	0.0011	CcSEcCtD
Alfentanil—Confusional state—Ramipril—type 2 diabetes mellitus	0.00014	0.00109	CcSEcCtD
Alfentanil—Pruritus—Orlistat—type 2 diabetes mellitus	0.00014	0.00109	CcSEcCtD
Alfentanil—Fatigue—Losartan—type 2 diabetes mellitus	0.00014	0.00108	CcSEcCtD
Alfentanil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000139	0.00108	CcSEcCtD
Alfentanil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000139	0.00107	CcSEcCtD
Alfentanil—Pain—Losartan—type 2 diabetes mellitus	0.000139	0.00107	CcSEcCtD
Alfentanil—Rash—Gliclazide—type 2 diabetes mellitus	0.000138	0.00107	CcSEcCtD
Alfentanil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000138	0.00106	CcSEcCtD
Alfentanil—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000137	0.00106	CcSEcCtD
Alfentanil—Headache—Gliclazide—type 2 diabetes mellitus	0.000137	0.00106	CcSEcCtD
Alfentanil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000137	0.00106	CcSEcCtD
Alfentanil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000136	0.00105	CcSEcCtD
Alfentanil—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000136	0.00105	CcSEcCtD
Alfentanil—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.00105	CcSEcCtD
Alfentanil—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000135	0.00104	CcSEcCtD
Alfentanil—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000134	0.00103	CcSEcCtD
Alfentanil—Dizziness—Valsartan—type 2 diabetes mellitus	0.000133	0.00103	CcSEcCtD
Alfentanil—Dizziness—Orlistat—type 2 diabetes mellitus	0.000131	0.00101	CcSEcCtD
Alfentanil—Asthenia—Metformin—type 2 diabetes mellitus	0.000131	0.00101	CcSEcCtD
Alfentanil—Hypotension—Ramipril—type 2 diabetes mellitus	0.00013	0.00101	CcSEcCtD
Alfentanil—Nausea—Gliclazide—type 2 diabetes mellitus	0.00013	0.001	CcSEcCtD
Alfentanil—Pruritus—Metformin—type 2 diabetes mellitus	0.000129	0.001	CcSEcCtD
Alfentanil—Urticaria—Losartan—type 2 diabetes mellitus	0.000129	0.000998	CcSEcCtD
Alfentanil—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000128	0.000993	CcSEcCtD
Alfentanil—Vomiting—Valsartan—type 2 diabetes mellitus	0.000128	0.000987	CcSEcCtD
Alfentanil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000127	0.000983	CcSEcCtD
Alfentanil—Rash—Valsartan—type 2 diabetes mellitus	0.000127	0.000979	CcSEcCtD
Alfentanil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000126	0.000978	CcSEcCtD
Alfentanil—Vomiting—Orlistat—type 2 diabetes mellitus	0.000126	0.000975	CcSEcCtD
Alfentanil—Headache—Valsartan—type 2 diabetes mellitus	0.000126	0.000973	CcSEcCtD
Alfentanil—Rash—Orlistat—type 2 diabetes mellitus	0.000125	0.000967	CcSEcCtD
Alfentanil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000125	0.000966	CcSEcCtD
Alfentanil—Headache—Orlistat—type 2 diabetes mellitus	0.000124	0.000961	CcSEcCtD
Alfentanil—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000957	CcSEcCtD
Alfentanil—Somnolence—Ramipril—type 2 diabetes mellitus	0.000124	0.000957	CcSEcCtD
Alfentanil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000122	0.000944	CcSEcCtD
Alfentanil—Dizziness—Metformin—type 2 diabetes mellitus	0.000121	0.000935	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.00093	CcSEcCtD
Alfentanil—Fatigue—Ramipril—type 2 diabetes mellitus	0.00012	0.000928	CcSEcCtD
Alfentanil—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00012	0.000925	CcSEcCtD
Alfentanil—Nausea—Valsartan—type 2 diabetes mellitus	0.000119	0.000922	CcSEcCtD
Alfentanil—Nausea—Orlistat—type 2 diabetes mellitus	0.000118	0.000911	CcSEcCtD
Alfentanil—Asthenia—Losartan—type 2 diabetes mellitus	0.000116	0.000901	CcSEcCtD
Alfentanil—Vomiting—Metformin—type 2 diabetes mellitus	0.000116	0.000899	CcSEcCtD
Alfentanil—Rash—Metformin—type 2 diabetes mellitus	0.000115	0.000891	CcSEcCtD
Alfentanil—Dermatitis—Metformin—type 2 diabetes mellitus	0.000115	0.000891	CcSEcCtD
Alfentanil—Pruritus—Losartan—type 2 diabetes mellitus	0.000115	0.000888	CcSEcCtD
Alfentanil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000115	0.000887	CcSEcCtD
Alfentanil—Headache—Metformin—type 2 diabetes mellitus	0.000115	0.000886	CcSEcCtD
Alfentanil—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000114	0.000882	CcSEcCtD
Alfentanil—Urticaria—Ramipril—type 2 diabetes mellitus	0.000111	0.000855	CcSEcCtD
Alfentanil—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00011	0.000851	CcSEcCtD
Alfentanil—Fentanyl—CYP3A4—type 2 diabetes mellitus	0.00011	0.254	CrCbGaD
Alfentanil—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00011	0.000848	CcSEcCtD
Alfentanil—Rash—Irbesartan—type 2 diabetes mellitus	0.000109	0.000841	CcSEcCtD
Alfentanil—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000109	0.00084	CcSEcCtD
Alfentanil—Nausea—Metformin—type 2 diabetes mellitus	0.000109	0.00084	CcSEcCtD
Alfentanil—Headache—Irbesartan—type 2 diabetes mellitus	0.000108	0.000836	CcSEcCtD
Alfentanil—Dizziness—Losartan—type 2 diabetes mellitus	0.000107	0.00083	CcSEcCtD
Alfentanil—Vomiting—Losartan—type 2 diabetes mellitus	0.000103	0.000798	CcSEcCtD
Alfentanil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000103	0.000793	CcSEcCtD
Alfentanil—Nausea—Irbesartan—type 2 diabetes mellitus	0.000102	0.000793	CcSEcCtD
Alfentanil—Rash—Losartan—type 2 diabetes mellitus	0.000102	0.000792	CcSEcCtD
Alfentanil—Dermatitis—Losartan—type 2 diabetes mellitus	0.000102	0.000791	CcSEcCtD
Alfentanil—Headache—Losartan—type 2 diabetes mellitus	0.000102	0.000787	CcSEcCtD
Alfentanil—Asthenia—Ramipril—type 2 diabetes mellitus	9.99e-05	0.000772	CcSEcCtD
Alfentanil—Pruritus—Ramipril—type 2 diabetes mellitus	9.85e-05	0.000762	CcSEcCtD
Alfentanil—Nausea—Losartan—type 2 diabetes mellitus	9.64e-05	0.000746	CcSEcCtD
Alfentanil—Dizziness—Ramipril—type 2 diabetes mellitus	9.21e-05	0.000712	CcSEcCtD
Alfentanil—Vomiting—Ramipril—type 2 diabetes mellitus	8.85e-05	0.000685	CcSEcCtD
Alfentanil—Rash—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000679	CcSEcCtD
Alfentanil—Dermatitis—Ramipril—type 2 diabetes mellitus	8.77e-05	0.000678	CcSEcCtD
Alfentanil—Headache—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000674	CcSEcCtD
Alfentanil—Nausea—Ramipril—type 2 diabetes mellitus	8.27e-05	0.00064	CcSEcCtD
Alfentanil—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	8.36e-06	0.000149	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	8.34e-06	0.000148	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	8.32e-06	0.000148	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	8.27e-06	0.000147	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.26e-06	0.000147	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	8.24e-06	0.000147	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	8.21e-06	0.000146	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CETP—type 2 diabetes mellitus	8.11e-06	0.000144	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.11e-06	0.000144	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.11e-06	0.000144	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	8.07e-06	0.000144	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	8.04e-06	0.000143	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	8.01e-06	0.000143	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	8.01e-06	0.000143	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.95e-06	0.000142	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	7.95e-06	0.000141	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	7.95e-06	0.000141	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	7.92e-06	0.000141	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	7.92e-06	0.000141	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.9e-06	0.000141	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.84e-06	0.00014	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	7.83e-06	0.000139	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	7.73e-06	0.000138	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	7.72e-06	0.000137	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.72e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	7.59e-06	0.000135	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	7.59e-06	0.000135	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.56e-06	0.000135	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.56e-06	0.000135	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	7.54e-06	0.000134	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	7.54e-06	0.000134	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	7.54e-06	0.000134	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.54e-06	0.000134	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.54e-06	0.000134	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.54e-06	0.000134	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.52e-06	0.000134	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	7.42e-06	0.000132	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	7.41e-06	0.000132	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CTGF—type 2 diabetes mellitus	7.4e-06	0.000132	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.38e-06	0.000131	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	7.37e-06	0.000131	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	7.37e-06	0.000131	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	7.37e-06	0.000131	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	7.34e-06	0.000131	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.32e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	7.28e-06	0.00013	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.23e-06	0.000129	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.23e-06	0.000129	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.23e-06	0.000129	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	7.21e-06	0.000128	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.19e-06	0.000128	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	7.18e-06	0.000128	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	7.11e-06	0.000127	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	7.09e-06	0.000126	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	7.05e-06	0.000126	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	6.98e-06	0.000124	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.96e-06	0.000124	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.96e-06	0.000124	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	6.93e-06	0.000123	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	6.91e-06	0.000123	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	6.9e-06	0.000123	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.88e-06	0.000122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.86e-06	0.000122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.85e-06	0.000122	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.83e-06	0.000122	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	6.83e-06	0.000122	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	6.82e-06	0.000121	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	6.82e-06	0.000121	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.74e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.72e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.72e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.72e-06	0.00012	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.72e-06	0.00012	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.72e-06	0.00012	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	6.65e-06	0.000118	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.64e-06	0.000118	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.62e-06	0.000118	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.61e-06	0.000118	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.61e-06	0.000118	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.61e-06	0.000118	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	6.54e-06	0.000116	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.54e-06	0.000116	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GCG—type 2 diabetes mellitus	6.54e-06	0.000116	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	6.54e-06	0.000116	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	6.51e-06	0.000116	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.49e-06	0.000115	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.43e-06	0.000114	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	6.43e-06	0.000114	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.33e-06	0.000113	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.32e-06	0.000112	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.3e-06	0.000112	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.29e-06	0.000112	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	6.24e-06	0.000111	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	6.07e-06	0.000108	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.04e-06	0.000108	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	6.02e-06	0.000107	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.99e-06	0.000107	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.98e-06	0.000106	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.98e-06	0.000106	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.96e-06	0.000106	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.92e-06	0.000105	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	5.9e-06	0.000105	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SRC—type 2 diabetes mellitus	5.88e-06	0.000105	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.83e-06	0.000104	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.83e-06	0.000104	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.81e-06	0.000103	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.74e-06	0.000102	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.73e-06	0.000102	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.73e-06	0.000102	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	5.73e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.71e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.71e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.71e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.71e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.66e-06	0.000101	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.65e-06	0.0001	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.64e-06	0.0001	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GNB3—type 2 diabetes mellitus	5.64e-06	0.0001	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	5.61e-06	9.99e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.59e-06	9.95e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.55e-06	9.88e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.55e-06	9.87e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAT—type 2 diabetes mellitus	5.53e-06	9.85e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.52e-06	9.83e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.48e-06	9.75e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	5.41e-06	9.63e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOB—type 2 diabetes mellitus	5.37e-06	9.56e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5.36e-06	9.55e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.27e-06	9.38e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	5.26e-06	9.37e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	5.25e-06	9.35e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	5.23e-06	9.3e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	5.18e-06	9.21e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	5.18e-06	9.21e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LPL—type 2 diabetes mellitus	5.13e-06	9.13e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	5.1e-06	9.07e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.09e-06	9.06e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.03e-06	8.96e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.03e-06	8.96e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	5.02e-06	8.94e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	5.01e-06	8.92e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GPX1—type 2 diabetes mellitus	5.01e-06	8.91e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.99e-06	8.89e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.94e-06	8.79e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.94e-06	8.79e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.94e-06	8.79e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.92e-06	8.75e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CD36—type 2 diabetes mellitus	4.87e-06	8.68e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.85e-06	8.63e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	4.81e-06	8.57e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.75e-06	8.46e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.74e-06	8.43e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	4.73e-06	8.43e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.71e-06	8.38e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.66e-06	8.29e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.66e-06	8.29e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	4.62e-06	8.22e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.58e-06	8.15e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.57e-06	8.13e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.54e-06	8.08e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.54e-06	8.08e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.54e-06	8.08e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARA—type 2 diabetes mellitus	4.53e-06	8.07e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.51e-06	8.03e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.5e-06	8e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.43e-06	7.89e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.4e-06	7.83e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AGT—type 2 diabetes mellitus	4.39e-06	7.81e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.39e-06	7.81e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.38e-06	7.79e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.35e-06	7.74e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CALM1—type 2 diabetes mellitus	4.32e-06	7.68e-05	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.31e-06	7.68e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOE—type 2 diabetes mellitus	4.3e-06	7.66e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.27e-06	7.6e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.27e-06	7.6e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.27e-06	7.59e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOA1—type 2 diabetes mellitus	4.25e-06	7.57e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.24e-06	7.55e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.22e-06	7.51e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.07e-06	7.25e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.07e-06	7.25e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.07e-06	7.25e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.05e-06	7.2e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.04e-06	7.19e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4e-06	7.11e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.99e-06	7.11e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.97e-06	7.07e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.96e-06	7.05e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.92e-06	6.97e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.91e-06	6.96e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.88e-06	6.9e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.85e-06	6.85e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.78e-06	6.73e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.77e-06	6.71e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.75e-06	6.67e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.74e-06	6.66e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.74e-06	6.66e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.72e-06	6.63e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.72e-06	6.63e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.72e-06	6.63e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.68e-06	6.55e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.68e-06	6.55e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—INS—type 2 diabetes mellitus	3.67e-06	6.54e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	3.65e-06	6.5e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.63e-06	6.45e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.53e-06	6.28e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.53e-06	6.28e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.42e-06	6.09e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.33e-06	5.92e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.28e-06	5.84e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.26e-06	5.81e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	3.22e-06	5.74e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NOS3—type 2 diabetes mellitus	3.22e-06	5.74e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.22e-06	5.73e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.04e-06	5.42e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.04e-06	5.42e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.03e-06	5.39e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.99e-06	5.32e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.95e-06	5.25e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.95e-06	5.25e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.9e-06	5.16e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.82e-06	5.03e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.82e-06	5.03e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.82e-06	5.02e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.77e-06	4.93e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.71e-06	4.83e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.7e-06	4.81e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.63e-06	4.68e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.6e-06	4.63e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.58e-06	4.6e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.51e-06	4.46e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.49e-06	4.44e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.45e-06	4.35e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.38e-06	4.23e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.37e-06	4.22e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.33e-06	4.15e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.32e-06	4.13e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.31e-06	4.12e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.29e-06	4.09e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.02e-06	3.6e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.98e-06	3.53e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.82e-06	3.24e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.74e-06	3.1e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.74e-06	3.1e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.72e-06	3.06e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.59e-06	2.83e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.48e-06	2.64e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.3e-06	2.31e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8e-07	1.42e-05	CbGpPWpGaD
